Ligand Pharmaceuticals
LGND
$70.06
Share price
-1.33%
Change (1 day)
-9.34%
Change (1 year)
Operating Margin for Ligand Pharmaceuticals (LGND)
Operating Margin as of April 2024 (TTM): 17.06%
According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 17.06%. At the end of 2021 the company had an Operating Margin of 17.07%.
Operating Margin history for Ligand Pharmaceuticals from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 17.07% | -401.92% |
| 2020 | -5.65% | -100.85% |
| 2019 | 662.31% | 860.82% |
| 2018 | 68.93% | 69.95% |
| 2017 | 40.56% | 455.27% |
| 2016 | 7.30% | -85.13% |
| 2015 | 49.13% | 180.53% |
| 2014 | 17.51% | -6.84% |
| 2013 | 18.80% | -252.66% |
| 2012 | -12.31% | 25.29% |
| 2011 | -9.83% | -84.98% |
| 2010 | -65.44% | 158.12% |
| 2009 | -25.35% | -92.9% |
| 2008 | -357.00% | -13.89% |
| 2007 | -414.58% | 235.33% |
| 2006 | -123.63% | -700.84% |
| 2005 | 20.58% | -174.92% |
| 2004 | -27.46% | 102.13% |
| 2003 | -13.59% | -45.63% |
| 2002 | -24.99% | -17.54% |
| 2001 | -30.31% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 34.11% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | 102.87% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | 44.55% | 🇺🇸 USA |
 Amgen AMGN | 34.59% | 102.75% | 🇺🇸 USA |
 Baxter BAX | -19.01% | -211.43% | 🇺🇸 USA |
 Merck MRK | 27.73% | 62.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 19.24% | 12.78% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 22.54% | 32.12% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | -109.76% | -743.38% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.